Crohn’s Disease

In inflammatory bowel disease, empiric or overall food avoidance increases the risk for food avoidance and avoidant/restrictive food intake disorder.

Patients and clinicians generally report suboptimal disease control at lower rates than those determined by Selecting Therapeutic Targets in IBD-II metrics.

Iron deficiency anemia is common in patients with Crohn’s disease and ulcerative colitis, but iron supplementation also could be an effective treatment.

Vitamin E has shown potential for targeting the underlying mechanisms of inflammatory bowel disease, but more research into its clinical application is needed.

Emerging evidence underscores the significant impact of diet on IBD development and treatment.

Targeted microbiota manipulation using probiotics, prebiotics, synbiotics, and fecal microbiota transplantation holds potential for IBD treatment.

Patients with inflammatory bowel diseases often experience insomnia and various mental health conditions that healthcare providers should monitor.